FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to a composition for relieving and/or treating musculoskeletal, articular and juxta-articular diseases, and painful muscle spasm. A pharmaceutical composition for relieving and/or treating musculoskeletal, articular and juxta-articular diseases, and painful muscle spasm, wherein the above composition is presented in the form of a solid dosage form containing a combination of ketoprofen and thiocolchicoside found in the free form or in the form of a salt, in the absence of direct contact in between when mixing the composition. Using the for relieving and/or treating the musculoskeletal and articular diseases, including ankylosing spondylitis, low back pain, osteoarthritis and rheumatoid arthritis, and the juxta-articular diseases, such as bursitis and tendonitis and painful muscle spasm. A method for preparing a tablet dosage form for relieving and/or treating the musculoskeletal, articular and juxta-articular diseases, and painful muscle spasm (versions).
EFFECT: composition is stable and characterised by the low impurity level.
11 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF CYCLOBENZAPRINE AND ITS USE | 2022 |
|
RU2794957C1 |
ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS | 2013 |
|
RU2657556C2 |
COMBINATION OF MIRTAZAPINE AND TIZANIDINE FOR USE IN PAIN DISORDERS | 2019 |
|
RU2736713C1 |
STABLE INJECTABLE COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE | 2013 |
|
RU2666993C2 |
DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
NEW THERAPEUTIC COMPOSITION FOR TREATING PAIN SYNDROME ACCOMPANYING SMOOTH MUSCLE SPASM | 2012 |
|
RU2497505C1 |
PHARMACEUTICAL COMPOSITIONS OF MONTELUCAST AND LEVOCETIRISINE | 2013 |
|
RU2677649C2 |
SPASMOLYTIC COMPOSITION, METHOD TO OBTAIN SPASMOLYTIC COMPOSITION | 1997 |
|
RU2182016C2 |
NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
COMBINED AGENT BASED ON NSIAD, MUSCLE RELAXANT AND VITAMIN | 2017 |
|
RU2711624C2 |
Authors
Dates
2013-09-27—Published
2009-01-22—Filed